Related by context. Frequent words. (Click for all words.) 87 investigational mTOR inhibitor 72 candidate AP# 70 candidate Zenvia 68 candidates bavituximab 68 Panzem R 68 candidate brentuximab vedotin 68 developing Zerenex TM 67 dipropionate 67 anticancer compound 67 R sorafenib tablets 66 Emergent marketed 65 sodium Injection 65 KNS # 65 GVAX R 65 pseudobulbar affect PBA 65 Inhalation Aerosol 65 Locteron ® 64 phenylketonuria PKU developed 64 Initiates Phase II 64 Onalta 64 Neo Urinary Conduit 64 inflammatory autoimmune diseases 64 refractory chronic lymphocytic 64 Receives Orphan Drug Designation 64 phenylalanine ammonia lyase 63 Potassium Chloride Sodium Ascorbate 63 PLK1 SNALP 63 HCV protease inhibitor 63 Proxinium TM 63 triple VEGF receptor 62 inhaled formulation 62 www.celgene.com 62 Genasense ® oblimersen 62 Kuvan R 62 PEG PAL PEGylated recombinant 62 Inc Therapeutic Competitors 62 topical anti infective 62 liposomal formulation 62 Presents Positive 62 deforolimus 62 www.vivus.com 62 ApoB SNALP 62 Chemokine Therapeutics 61 systemically administered 61 MKC# 61 JAK1 61 Therapeutic Competitors 61 Advancing Drugs 61 addressing idiopathic pulmonary 61 orally bioavailable 61 Genasense ® 61 Voreloxin 61 Vytorin combines 61 DNA RNA Medicines 61 Belimumab 61 Nexavar ® 61 HIV protease inhibitor Lexiva 61 http:/www.nabi.com 61 forodesine 61 BioGlue R 61 Dapagliflozin 60 BiTE R 60 http:/www.ariad.com 60 Sodium Sulfate Sodium Chloride 60 FACTIVE R gemifloxacin 60 New Chemical Entities 60 Inc. Nasdaq IMGN 60 ferric citrate 60 www.pozen.com 60 multi kinase inhibitor 60 histone deacetylase HDAC inhibitor 60 Pralatrexate 60 Genta Small Molecule 60 Daclizumab 60 CYC# 60 Enrolls First 60 Medarex logo 60 proteasome inhibitor 60 novel antibody therapeutics 60 Takeda Kyowa Hakko Kirin 60 Biolex Therapeutics 60 male hypogonadism licensed 60 Copegus R 60 www.schering plough.com 60 novel RNAi therapeutics 60 Ganite R gallium nitrate 60 Ixempra 60 www.delcath.com 60 Panzem R NCD 60 mucopolysaccharidosis VI MPS VI 60 Vivecon 60 Thiarabine 60 Inc. NASDAQ TRGT 60 humanized anti 60 Meets Primary Endpoint 60 fluoroquinolone class 59 Hematide TM 59 www.syntapharma.com 59 Brentuximab vedotin 59 www.implantsciences.com 59 Application MAA